Legend Biotech
Hybrid
Some members of the team work remotely, while others are co-located in one or more offices.
👥501-1,000
📍Piscataway
Legend Biotech
About Legend Biotech
Legend Biotech is a global, clinical-stage biotechnology company developing and manufacturing novel therapies.
Legend Biotech news and updates
Hillhouse Capital invested into Legend Biotech Corp. in $447M on May 14th 21'.
In a filing on May 14, Genscript disclosed Hillhouse’s plan of investing $300 million in Legend Biotech, its Nasdaq-listed cell therapy arm, together with a stock warrant worth $200 million in total.
Jan 1, 2021 | dealstreetasia.comLegend Biotech Corp. received financing of $250M in public offering on Jun 27th 22'.
Legend Biotech recently announced a $250 million proposed public offering.
Jan 1, 2022 | benzinga.comLegend Biotech Corp. receives financing of $250M in underwritten public offering
CAR-T firm Legend Biotech has announced plans to raise $250 million by selling American Depositary Shares (ADSs) in an underwritten public offering.
Jan 1, 2022 | pda.orgLegend Biotech Corp. hires Fang as senior vice president of Research
Dr. Fang comes to Legend Biotech from Zymeworks Inc, where he served as senior vice president of Research and oversaw the development of novel platforms and a portfolio of multi-functional biologics and antibody drug conjugates.
Jan 1, 2022 | legendbiotech.com